A proactive approach can help pharma realize the promise of end-to-end visibility and control over networks
The COVID-19 pandemic has tested the resilience of institutions, processes and systems across all industries and geographies, including the pharmaceutical supply chain. Escalating cold chain supply challenges, paired with increasing consumer pressures, have highlighted the urgent need for visibility at every node along the chain.
Continue reading on pharmamanufacturing.com.
